Search
01/01/2023
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
Jeria-Navarro S., Gomez-Gomez A., Park H.S., Calvo-Aranda E., Corominas H., Pou M.A., Diaz-Torne C.. Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature. Frontiers in Medicine. 2023; 9DOI:10.3389/fmed.2022.1089993. PMID:36714095. IF:3.100(Q1/2D).
01/01/2023
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Narváez J., Aburto M., Seoane-Mato D., Bonilla G., Acosta O., Candelas G., Cano-Jiménez E., Castellví I., González-Ruiz J.M., Corominas H., López-Muñiz B., Martín-López M., Robles-Pérez A., Mena-Vázquez N., Rodríguez-Portal J.A., Ortiz A.M., Sabater-Abad C., Castrejón I., dos Santos R., Garrote-Corral S., Maese J., Silva-Fernández L., Castañeda S., Valenzuela C.. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatologia Clinica. 2023; 19(2)DOI:10.1016/j.reuma.2021.12.006. PMID:35753951. IF:(Q/D).
01/01/2023
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., Marcos A.G.. Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023; 41(1)DOI:10.55563/clinexprheumatol/077ul6. PMID:35699067. IF:3.400(Q2/3D).
01/01/2023
Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis
Oteo J.A., Corominas H., Escudero R., Fariñas-Guerrero F., García-Moncó J.C., Goenaga M.A., Guillén S., Mascaró J.M., Portillo A.. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; 41(1)DOI:10.1016/j.eimc.2022.03.004. PMID:36621247. IF:2.600(Q3/6D).
01/01/2023
Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
Crespo-Lessmann A., Curto E., Medina, EFM, Palones E., Soler A.B., Maza S.S., Soto-Retes L., Plaza V.. Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia. Journal of Asthma and Allergy. 2023; 16DOI:10.2147/JAA.S389402. PMID:36699564. IF:3.700(Q1/3D).
01/01/2023
Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study
Molina J., Plaza V., Nuevo J., Gutiérrez M., Sicras-Mainar A., Valero A.. Clinical Consequences of the Overuse of Short-Acting ß2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2023.100232. PMID:37496866. IF:(Q/D).
01/01/2023
Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
Plaza V., Cañete C., Domingo C., Martínez Rivera C., Muñoz X.. Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma. Open Respiratory Archives. 2023; 5(2)DOI:10.1016/j.opresp.2022.100231. PMID:37496871. IF:(Q/D).
01/01/2023
Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study
Barroso B., Valverde-Monge M., Alobid I., Olaguibel J.M., Rial M.J., Quirce S., Arismendi E., Barranco P., Betancor D., Bobolea I., Cárdaba B., Cruz Carmona M.J., Curto E., Domínguez-Ortega J., González-Barcala F.J., Martínez-Rivera C., Mahíllo-Fernández I., Muñoz X., Picado C., Plaza V., Rodrigo Muñoz J.M., Soto-Retes L., Valero A., Del Pozo V., Mullol J., Sastre J.. Improvement in Olfaction in Patients With CRSwNP and Severe Asthma Taking Anti-IgE and Anti-IL-5 Biologics: A Real-Life Study. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(1)DOI:10.18176/jiaci.0812. PMID:35416154. IF:6.700(Q1/2D).